APO Research
Talk to an analyst

APO RESEARCH · REPORT

Pharmaceutical and Biopharmaceutical Safety Testing Service

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global Pharmaceutical and Biopharmaceutical Safety Testing Service Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

12 August 2026196 pages

Choose your research edition.

Industry ResearchPharmaceutical and Biopharmaceutical Safety Testing Service Industry Research Report 2026146 pages · $2,950 USDIndustry Growth & TrendsGlobal Pharmaceutical and Biopharmaceutical Safety Testing Service Industry Growth and Trends Forecast to 2032122 pages · $3,450 USDMarket StructureGlobal Pharmaceutical and Biopharmaceutical Safety Testing Service Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032196 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Pharmaceutical and Biopharmaceutical Safety Testing Service Market Outlook and Growth Opportunities 2026218 pages · $4,250 USDMarket Analysis & ForecastGlobal Pharmaceutical and Biopharmaceutical Safety Testing Service Market Analysis and Forecast 2026-2032194 pages · $4,950 USD

Market perspective

The global Pharmaceutical and Biopharmaceutical Safety Testing Service market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The US & Canada market for Pharmaceutical and Biopharmaceutical Safety Testing Service is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Pharmaceutical and Biopharmaceutical Safety Testing Service is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Pharmaceutical and Biopharmaceutical Safety Testing Service is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for Pharmaceutical and Biopharmaceutical Safety Testing Service is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Pharmaceutical and Biopharmaceutical Safety Testing Service include Eurofins Scientific, SGS, Q2 Solutions, Samsung Biologics, Texcell, WuXi Biologics, Wuhan Canvest Biotechnology, Centre Testing International (CTI) and Suzhou Liangchen Biotechnology, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Includes

This report provides an overview of the global Pharmaceutical and Biopharmaceutical Safety Testing Service market and its size, analyzing global market trends based on historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Pharmaceutical and Biopharmaceutical Safety Testing Service and revenue in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Pharmaceutical and Biopharmaceutical Safety Testing Service revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering revenue and growth rates—for 2021-2032, and evaluates and forecasts the Pharmaceutical and Biopharmaceutical Safety Testing Service market size, projected growth trends, production technologies, key applications, and end-use industries.

Pharmaceutical and Biopharmaceutical Safety Testing Service Segment by Company

Eurofins Scientific

SGS

Q2 Solutions

Samsung Biologics

Texcell

WuXi Biologics

Wuhan Canvest Biotechnology

Centre Testing International (CTI)

Suzhou Liangchen Biotechnology

JADE Biomedical

Standard Testing Group

Sino Tech World Biologicals

CAS Testing Technical Services

NTEK

Sino Biological

Miracle Points

Suzhou Cefety Bioscience

Zhejiang Hengyu Biological

Merck

Charles River Laboratories

Sartorius

Pharmaceutical and Biopharmaceutical Safety Testing Service Segment by Type

Raw Materials

Viral Banks

Cell Banks

Others

Pharmaceutical and Biopharmaceutical Safety Testing Service Segment by Application

Pharmaceutical and Biotechnology Companies

CROs and CDMOs

Academic and Research Institutions

Pharmaceutical and Biopharmaceutical Safety Testing Service Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Pharmaceutical and Biopharmaceutical Safety Testing Service market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Pharmaceutical and Biopharmaceutical Safety Testing Service and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Pharmaceutical and Biopharmaceutical Safety Testing Service.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. Revenue of Pharmaceutical and Biopharmaceutical Safety Testing Service in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Pharmaceutical and Biopharmaceutical Safety Testing Service industry.

Chapter 3: Detailed analysis of Pharmaceutical and Biopharmaceutical Safety Testing Service companies' competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Pharmaceutical and Biopharmaceutical Safety Testing Servicerevenue, gross margin, and recent development, etc.

Chapter 7: North America (US & Canada) by type, by application and by country, revenue for each segment.

Chapter 8: Europe by type, by application and by country, revenue for each segment.

Chapter 9: China by type, and by application, revenue for each segment.

Chapter 10: Asia (excluding China) by type, by application and by region, revenue for each segment.

Chapter 11: South America, Middle East & Africa by type, by application and by country, revenue for each segment.

Chapter 12: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Pharmaceutical and Biopharmaceutical Safety Testing Service Market Size Growth Rate by Type (US$ Million): 2021 VS 2025 VS 2032 Table 2. Key Players of Raw Materials Table 3. Key Players of Viral Banks Table 4. Key Players of Cell Banks Table 3. Key Players of Others Table 4. Global Pharmaceutical and Biopharmaceutical Safety Testing Service Market Size Growth Rate by Application (US$ Million): 2021 VS 2025 VS 2032 Table 5. Key Players of Pharmaceutical and Biotechnology Companies Table 6. Key Players of CROs and CDMOs Table 7. Key Players of Academic and Research Institutions Table 8. Global Pharmaceutical and Biopharmaceutical Safety Testing Service Market Size Growth Rate (CAGR) by Region (US$ Million): 2021 VS 2025 VS 2032 Table 9. Global Pharmaceutical and Biopharmaceutical Safety Testing Service Market Size by Region (2021-2026) & (US$ Million) Table 10. Global Pharmaceutical and Biopharmaceutical Safety Testing Service Market Share by Region (2021-2026) Table 11. Global Pharmaceutical and Biopharmaceutical Safety Testing Service Market Size by Region (2027-2032) & (US$ Million) Table 12. Global Pharmaceutical and Biopharmaceutical Safety Testing Service Market Share by Region (2027-2032) Table 13. Pharmaceutical and Biopharmaceutical Safety Testing Service Industry Trends Table 14. Pharmaceutical and Biopharmaceutical Safety Testing Service Industry Drivers Table 15. Pharmaceutical and Biopharmaceutical Safety Testing Service Industry Opportunities and Challenges Table 16. Pharmaceutical and Biopharmaceutical Safety Testing Service Industry Restraints Table 17. Global Pharmaceutical and Biopharmaceutical Safety Testing Service Revenue by Company (US$ Million) & (2021-2026) Table 18. Global Pharmaceutical and Biopharmaceutical Safety Testing Service Revenue Market Share by Company (2021-2026) Table 19. Global Pharmaceutical and Biopharmaceutical Safety Testing Service Players Revenue Ranking, 2024 VS 2025 VS 2026 Table 20. Global Pharmaceutical and Biopharmaceutical Safety Testing Service Key Company Head Office and Area Served Table 21. Global Pharmaceutical and Biopharmaceutical Safety Testing Service Company, Product Type & Application Table 22. Global Pharmaceutical and Biopharmaceutical Safety Testing Service Company Establishment Date Table 23. Global Company Market Concentration Ratio (CR5 and HHI) Table 24. Global Pharmaceutical and Biopharmaceutical Safety Testing Service by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 25. Global Pharmaceutical and Biopharmaceutical Safety Testing Service Market Size by Type 2021 VS 2025 VS 2032 (US$ Million) Table 26. Global Pharmaceutical and Biopharmaceutical Safety Testing Service Market Size by Type (2021-2026) & (US$ Million) Table 27. Global Pharmaceutical and Biopharmaceutical Safety Testing Service Market Size by Type (2027-2032) & (US$ Million) Table 28. Global Pharmaceutical and Biopharmaceutical Safety Testing Service Revenue Market Share by Type (2021-2026) Table 29. Global Pharmaceutical and Biopharmaceutical Safety Testing Service Revenue Market Share by Type (2027-2032) Table 30. Global Pharmaceutical and Biopharmaceutical Safety Testing Service Market Size by Application 2021 VS 2025 VS 2032 (US$ Million) Table 31. Global Pharmaceutical and Biopharmaceutical Safety Testing Service Market Size by Application (2021-2026) & (US$ Million) Table 32. Global Pharmaceutical and Biopharmaceutical Safety Testing Service Market Size by Application (2027-2032) & (US$ Million) Table 33. Global Pharmaceutical and Biopharmaceutical Safety Testing Service Revenue Market Share by Application (2021-2026) Table 34. Global Pharmaceutical and Biopharmaceutical Safety Testing Service Revenue Market Share by Application (2027-2032) Table 35. Eurofins Scientific Company Information Table 36. Eurofins Scientific Business Overview Table 37. Eurofins Scientific Pharmaceutical and Biopharmaceutical Safety Testing Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 38. Eurofins Scientific Pharmaceutical and Biopharmaceutical Safety Testing Service Product Portfolio Table 39. Eurofins Scientific Recent Development Table 40. SGS Company Information Table 41. SGS Business Overview Table 42. SGS Pharmaceutical and Biopharmaceutical Safety Testing Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 43. SGS Pharmaceutical and Biopharmaceutical Safety Testing Service Product Portfolio Table 44. SGS Recent Development Table 45. Q2 Solutions Company Information Table 46. Q2 Solutions Business Overview Table 47. Q2 Solutions Pharmaceutical and Biopharmaceutical Safety Testing Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 48. Q2 Solutions Pharmaceutical and Biopharmaceutical Safety Testing Service Product Portfolio Table 49. Q2 Solutions Recent Development Table 50. Samsung Biologics Company Information Table 51. Samsung Biologics Business Overview Table 52. Samsung Biologics Pharmaceutical and Biopharmaceutical Safety Testing Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 53. Samsung Biologics Pharmaceutical and Biopharmaceutical Safety Testing Service Product Portfolio Table 54. Samsung Biologics Recent Development Table 55. Texcell Company Information Table 56. Texcell Business Overview Table 57. Texcell Pharmaceutical and Biopharmaceutical Safety Testing Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 58. Texcell Pharmaceutical and Biopharmaceutical Safety Testing Service Product Portfolio Table 59. Texcell Recent Development Table 60. WuXi Biologics Company Information Table 61. WuXi Biologics Business Overview Table 62. WuXi Biologics Pharmaceutical and Biopharmaceutical Safety Testing Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 63. WuXi Biologics Pharmaceutical and Biopharmaceutical Safety Testing Service Product Portfolio Table 64. WuXi Biologics Recent Development Table 65. Wuhan Canvest Biotechnology Company Information Table 66. Wuhan Canvest Biotechnology Business Overview Table 67. Wuhan Canvest Biotechnology Pharmaceutical and Biopharmaceutical Safety Testing Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 68. Wuhan Canvest Biotechnology Pharmaceutical and Biopharmaceutical Safety Testing Service Product Portfolio Table 69. Wuhan Canvest Biotechnology Recent Development Table 70. Centre Testing International (CTI) Company Information Table 71. Centre Testing International (CTI) Business Overview Table 72. Centre Testing International (CTI) Pharmaceutical and Biopharmaceutical Safety Testing Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 73. Centre Testing International (CTI) Pharmaceutical and Biopharmaceutical Safety Testing Service Product Portfolio Table 74. Centre Testing International (CTI) Recent Development Table 75. Suzhou Liangchen Biotechnology Company Information Table 76. Suzhou Liangchen Biotechnology Business Overview Table 77. Suzhou Liangchen Biotechnology Pharmaceutical and Biopharmaceutical Safety Testing Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 78. Suzhou Liangchen Biotechnology Pharmaceutical and Biopharmaceutical Safety Testing Service Product Portfolio Table 79. Suzhou Liangchen Biotechnology Recent Development Table 80. JADE Biomedical Company Information Table 81. JADE Biomedical Business Overview Table 82. JADE Biomedical Pharmaceutical and Biopharmaceutical Safety Testing Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 83. JADE Biomedical Pharmaceutical and Biopharmaceutical Safety Testing Service Product Portfolio Table 84. JADE Biomedical Recent Development Table 85. Standard Testing Group Company Information Table 86. Standard Testing Group Business Overview Table 87. Standard Testing Group Pharmaceutical and Biopharmaceutical Safety Testing Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 88. Standard Testing Group Pharmaceutical and Biopharmaceutical Safety Testing Service Product Portfolio Table 89. Standard Testing Group Recent Development Table 90. Sino Tech World Biologicals Company Information Table 91. Sino Tech World Biologicals Business Overview Table 92. Sino Tech World Biologicals Pharmaceutical and Biopharmaceutical Safety Testing Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 93. Sino Tech World Biologicals Pharmaceutical and Biopharmaceutical Safety Testing Service Product Portfolio Table 94. Sino Tech World Biologicals Recent Development Table 95. CAS Testing Technical Services Company Information Table 96. CAS Testing Technical Services Business Overview Table 97. CAS Testing Technical Services Pharmaceutical and Biopharmaceutical Safety Testing Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 98. CAS Testing Technical Services Pharmaceutical and Biopharmaceutical Safety Testing Service Product Portfolio Table 99. CAS Testing Technical Services Recent Development Table 100. NTEK Company Information Table 101. NTEK Business Overview Table 102. NTEK Pharmaceutical and Biopharmaceutical Safety Testing Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 103. NTEK Pharmaceutical and Biopharmaceutical Safety Testing Service Product Portfolio Table 104. NTEK Recent Development Table 105. Sino Biological Company Information Table 106. Sino Biological Business Overview Table 107. Sino Biological Pharmaceutical and Biopharmaceutical Safety Testing Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 108. Sino Biological Pharmaceutical and Biopharmaceutical Safety Testing Service Product Portfolio Table 109. Sino Biological Recent Development Table 110. Miracle Points Company Information Table 111. Miracle Points Business Overview Table 112. Miracle Points Pharmaceutical and Biopharmaceutical Safety Testing Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 113. Miracle Points Pharmaceutical and Biopharmaceutical Safety Testing Service Product Portfolio Table 114. Miracle Points Recent Development Table 115. Suzhou Cefety Bioscience Company Information Table 116. Suzhou Cefety Bioscience Business Overview Table 117. Suzhou Cefety Bioscience Pharmaceutical and Biopharmaceutical Safety Testing Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 118. Suzhou Cefety Bioscience Pharmaceutical and Biopharmaceutical Safety Testing Service Product Portfolio Table 119. Suzhou Cefety Bioscience Recent Development Table 120. Zhejiang Hengyu Biological Company Information Table 121. Zhejiang Hengyu Biological Business Overview Table 122. Zhejiang Hengyu Biological Pharmaceutical and Biopharmaceutical Safety Testing Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 123. Zhejiang Hengyu Biological Pharmaceutical and Biopharmaceutical Safety Testing Service Product Portfolio Table 124. Zhejiang Hengyu Biological Recent Development Table 125. Merck Company Information Table 126. Merck Business Overview Table 127. Merck Pharmaceutical and Biopharmaceutical Safety Testing Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 128. Merck Pharmaceutical and Biopharmaceutical Safety Testing Service Product Portfolio Table 129. Merck Recent Development Table 130. Charles River Laboratories Company Information Table 131. Charles River Laboratories Business Overview Table 132. Charles River Laboratories Pharmaceutical and Biopharmaceutical Safety Testing Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 133. Charles River Laboratories Pharmaceutical and Biopharmaceutical Safety Testing Service Product Portfolio Table 134. Charles River Laboratories Recent Development Table 135. Sartorius Company Information Table 136. Sartorius Business Overview Table 137. Sartorius Pharmaceutical and Biopharmaceutical Safety Testing Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 138. Sartorius Pharmaceutical and Biopharmaceutical Safety Testing Service Product Portfolio Table 139. Sartorius Recent Development Table 140. North America Pharmaceutical and Biopharmaceutical Safety Testing Service Market Size by Type (2021-2026) & (US$ Million) Table 141. North America Pharmaceutical and Biopharmaceutical Safety Testing Service Market Size by Type (2027-2032) & (US$ Million) Table 142. North America Pharmaceutical and Biopharmaceutical Safety Testing Service Market Size by Application (2021-2026) & (US$ Million) Table 143. North America Pharmaceutical and Biopharmaceutical Safety Testing Service Market Size by Application (2027-2032) & (US$ Million) Table 144. North America Pharmaceutical and Biopharmaceutical Safety Testing Service Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 145. North America Pharmaceutical and Biopharmaceutical Safety Testing Service Market Size by Country (2021-2026) Table 146. North America Pharmaceutical and Biopharmaceutical Safety Testing Service Market Size by Country (2027-2032) Table 147. Europe Pharmaceutical and Biopharmaceutical Safety Testing Service Market Size by Type (2021-2026) & (US$ Million) Table 148. Europe Pharmaceutical and Biopharmaceutical Safety Testing Service Market Size by Type (2027-2032) & (US$ Million) Table 149. Europe Pharmaceutical and Biopharmaceutical Safety Testing Service Market Size by Application (2021-2026) & (US$ Million) Table 150. Europe Pharmaceutical and Biopharmaceutical Safety Testing Service Market Size by Application (2027-2032) & (US$ Million) Table 151. Europe Pharmaceutical and Biopharmaceutical Safety Testing Service Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 152. Europe Pharmaceutical and Biopharmaceutical Safety Testing Service Market Size by Country (2021-2026) Table 153. Europe Pharmaceutical and Biopharmaceutical Safety Testing Service Market Size by Country (2027-2032) Table 154. China Pharmaceutical and Biopharmaceutical Safety Testing Service Market Size by Type (2021-2026) & (US$ Million) Table 155. China Pharmaceutical and Biopharmaceutical Safety Testing Service Market Size by Type (2027-2032) & (US$ Million) Table 156. China Pharmaceutical and Biopharmaceutical Safety Testing Service Market Size by Application (2021-2026) & (US$ Million) Table 157. China Pharmaceutical and Biopharmaceutical Safety Testing Service Market Size by Application (2027-2032) & (US$ Million) Table 158. Asia Pharmaceutical and Biopharmaceutical Safety Testing Service Market Size by Type (2021-2026) & (US$ Million) Table 159. Asia Pharmaceutical and Biopharmaceutical Safety Testing Service Market Size by Type (2027-2032) & (US$ Million) Table 160. Asia Pharmaceutical and Biopharmaceutical Safety Testing Service Market Size by Application (2021-2026) & (US$ Million) Table 161. Asia Pharmaceutical and Biopharmaceutical Safety Testing Service Market Size by Application (2027-2032) & (US$ Million) Table 162. Asia Pharmaceutical and Biopharmaceutical Safety Testing Service Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 163. Asia Pharmaceutical and Biopharmaceutical Safety Testing Service Market Size by Country (2021-2026) Table 164. Asia Pharmaceutical and Biopharmaceutical Safety Testing Service Market Size by Country (2027-2032) Table 165. South America, Middle East & Africa Pharmaceutical and Biopharmaceutical Safety Testing Service Market Size by Type (2021-2026) & (US$ Million) Table 166. South America, Middle East & Africa Pharmaceutical and Biopharmaceutical Safety Testing Service Market Size by Type (2027-2032) & (US$ Million) Table 167. South America, Middle East & Africa Pharmaceutical and Biopharmaceutical Safety Testing Service Market Size by Application (2021-2026) & (US$ Million) Table 168. South America, Middle East & Africa Pharmaceutical and Biopharmaceutical Safety Testing Service Market Size by Application (2027-2032) & (US$ Million) Table 169. South America, Middle East & Africa Pharmaceutical and Biopharmaceutical Safety Testing Service Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 170. South America, Middle East & Africa Pharmaceutical and Biopharmaceutical Safety Testing Service Market Size by Country (2021-2026) Table 171. South America, Middle East & Africa Pharmaceutical and Biopharmaceutical Safety Testing Service Market Size by Country (2027-2032) Table 172. Research Programs/Design for This Report Table 173. Authors List of This Report Table 174. Secondary Sources Table 175. Primary Sources List of Figures Figure 1. Pharmaceutical and Biopharmaceutical Safety Testing Service Product Image Figure 2. Global Pharmaceutical and Biopharmaceutical Safety Testing Service Market Size Growth Rate by Type, 2021 VS 2025 VS 2032 (US$ Million) Figure 3. Global Pharmaceutical and Biopharmaceutical Safety Testing Service Market Share by Type: 2025 VS 2032 Figure 4. Raw Materials Image Figure 5. Viral Banks Image Figure 6. Cell Banks Image Figure 7. Others Image Figure 8. Global Pharmaceutical and Biopharmaceutical Safety Testing Service Market Size Growth Rate by Application, 2021 VS 2025 VS 2032 (US$ Million) Figure 9. Global Pharmaceutical and Biopharmaceutical Safety Testing Service Market Share by Application: 2025 VS 2032 Figure 10. Pharmaceutical and Biotechnology Companies Image Figure 11. CROs and CDMOs Image Figure 12. Academic and Research Institutions Image Figure 13. Global Pharmaceutical and Biopharmaceutical Safety Testing Service Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 14. Global Pharmaceutical and Biopharmaceutical Safety Testing Service Market Size (2021-2032) & (US$ Million) Figure 15. Global Pharmaceutical and Biopharmaceutical Safety Testing Service Market Share by Region: 2025 VS 2032 Figure 16. Years Considered Figure 17. Global Pharmaceutical and Biopharmaceutical Safety Testing Service Market Share by Players in 2025 Figure 18. Global Top 5 and 10 Pharmaceutical and Biopharmaceutical Safety Testing Service Players Market Share by Revenue in 2025 Figure 19. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 20. Global Pharmaceutical and Biopharmaceutical Safety Testing Service Market Size by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 21. Global Pharmaceutical and Biopharmaceutical Safety Testing Service Revenue Market Share by Type (2021-2032) Figure 22. Global Pharmaceutical and Biopharmaceutical Safety Testing Service Market Size by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 23. Global Pharmaceutical and Biopharmaceutical Safety Testing Service Revenue Market Share by Application (2021-2032) Figure 24. North America Pharmaceutical and Biopharmaceutical Safety Testing Service Market Size (2021-2032) & (US$ Million) Figure 25. North America Pharmaceutical and Biopharmaceutical Safety Testing Service Market Share by Type (2021-2032) Figure 26. North America Pharmaceutical and Biopharmaceutical Safety Testing Service Market Share by Application (2021-2032) Figure 27. North America Pharmaceutical and Biopharmaceutical Safety Testing Service Market Share by Country (2021-2032) Figure 28. United States Pharmaceutical and Biopharmaceutical Safety Testing Service Market Size (2021-2032) & (US$ Million) Figure 29. Canada Pharmaceutical and Biopharmaceutical Safety Testing Service Market Size (2021-2032) & (US$ Million) Figure 30. Mexico Pharmaceutical and Biopharmaceutical Safety Testing Service Market Size (2021-2032) & (US$ Million) Figure 31. Europe Pharmaceutical and Biopharmaceutical Safety Testing Service Market Size (2021-2032) & (US$ Million) Figure 32. Europe Pharmaceutical and Biopharmaceutical Safety Testing Service Market Share by Type (2021-2032) Figure 33. Europe Pharmaceutical and Biopharmaceutical Safety Testing Service Market Share by Application (2021-2032) Figure 34. Europe Pharmaceutical and Biopharmaceutical Safety Testing Service Market Share by Country (2021-2032) Figure 35. Germany Pharmaceutical and Biopharmaceutical Safety Testing Service Market Size (2021-2032) & (US$ Million) Figure 36. France Pharmaceutical and Biopharmaceutical Safety Testing Service Market Size (2021-2032) & (US$ Million) Figure 37. U.K. Pharmaceutical and Biopharmaceutical Safety Testing Service Market Size (2021-2032) & (US$ Million) Figure 38. Italy Pharmaceutical and Biopharmaceutical Safety Testing Service Market Size (2021-2032) & (US$ Million) Figure 39. Russia Pharmaceutical and Biopharmaceutical Safety Testing Service Market Size (2021-2032) & (US$ Million) Figure 40. Nordic Countries Pharmaceutical and Biopharmaceutical Safety Testing Service Market Size (2021-2032) & (US$ Million) Figure 41. China Pharmaceutical and Biopharmaceutical Safety Testing Service Market Size (2021-2032) & (US$ Million) Figure 42. China Pharmaceutical and Biopharmaceutical Safety Testing Service Market Share by Type (2021-2032) Figure 43. China Pharmaceutical and Biopharmaceutical Safety Testing Service Market Share by Application (2021-2032) Figure 44. Asia Pharmaceutical and Biopharmaceutical Safety Testing Service Market Size (2021-2032) & (US$ Million) Figure 45. Asia Pharmaceutical and Biopharmaceutical Safety Testing Service Market Share by Type (2021-2032) Figure 46. Asia Pharmaceutical and Biopharmaceutical Safety Testing Service Market Share by Application (2021-2032) Figure 47. Asia Pharmaceutical and Biopharmaceutical Safety Testing Service Market Share by Country (2021-2032) Figure 48. Japan Pharmaceutical and Biopharmaceutical Safety Testing Service Market Size (2021-2032) & (US$ Million) Figure 49. South Korea Pharmaceutical and Biopharmaceutical Safety Testing Service Market Size (2021-2032) & (US$ Million) Figure 50. Taiwan Pharmaceutical and Biopharmaceutical Safety Testing Service Market Size (2021-2032) & (US$ Million) Figure 51. Southeast Asia Pharmaceutical and Biopharmaceutical Safety Testing Service Market Size (2021-2032) & (US$ Million) Figure 52. India Pharmaceutical and Biopharmaceutical Safety Testing Service Market Size (2021-2032) & (US$ Million) Figure 53. Australia Pharmaceutical and Biopharmaceutical Safety Testing Service Market Size (2021-2032) & (US$ Million) Figure 54. South America, Middle East & Africa Pharmaceutical and Biopharmaceutical Safety Testing Service Market Size (2021-2032) & (US$ Million) Figure 55. South America, Middle East & Africa Pharmaceutical and Biopharmaceutical Safety Testing Service Market Share by Type (2021-2032) Figure 56. South America, Middle East & Africa Pharmaceutical and Biopharmaceutical Safety Testing Service Market Share by Application (2021-2032) Figure 57. South America, Middle East & Africa Pharmaceutical and Biopharmaceutical Safety Testing Service Market Share by Country (2021-2032) Figure 58. Brazil Pharmaceutical and Biopharmaceutical Safety Testing Service Market Size (2021-2032) & (US$ Million) Figure 59. South Africa Pharmaceutical and Biopharmaceutical Safety Testing Service Market Size (2021-2032) & (US$ Million) Figure 60. Saudi Arabia Pharmaceutical and Biopharmaceutical Safety Testing Service Market Size (2021-2032) & (US$ Million) Figure 61. Turkey Pharmaceutical and Biopharmaceutical Safety Testing Service Market Size (2021-2032) & (US$ Million) Figure 62. Argentina Pharmaceutical and Biopharmaceutical Safety Testing Service Market Size (2021-2032) & (US$ Million) Figure 63. UAE Pharmaceutical and Biopharmaceutical Safety Testing Service Market Size (2021-2032) & (US$ Million) Figure 64. Egypt Pharmaceutical and Biopharmaceutical Safety Testing Service Market Size (2021-2032) & (US$ Million) Figure 65. Chile Pharmaceutical and Biopharmaceutical Safety Testing Service Market Size (2021-2032) & (US$ Million) Figure 66. Research Process Figure 67. Key Executives Interviewed

Scope & coverage.

Types
  • Raw Materials
  • Viral Banks
  • Cell Banks
  • Others
Applications
  • Pharmaceutical and Biotechnology Companies
  • CROs and CDMOs
  • Academic and Research Institutions
Companies covered
  • Eurofins Scientific
  • SGS
  • Q2 Solutions
  • Samsung Biologics
  • Texcell
  • WuXi Biologics
  • Wuhan Canvest Biotechnology
  • Centre Testing International (CTI)
  • Suzhou Liangchen Biotechnology
  • JADE Biomedical
  • Standard Testing Group
  • Sino Tech World Biologicals
  • CAS Testing Technical Services
  • NTEK
  • Sino Biological
  • Miracle Points
  • Suzhou Cefety Bioscience
  • Zhejiang Hengyu Biological
  • Merck
  • Charles River Laboratories
  • Sartorius

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Market Analysis by Type
  3. 1.2.1 Global Pharmaceutical and Biopharmaceutical Safety Testing Service Market Size Growth Rate by Type: 2021 VS 2025 VS 2032
  4. 1.2.2 Raw Materials
  5. 1.2.3 Viral Banks
  6. 1.2.4 Cell Banks
  7. 1.2.5 Others
  8. 1.3 Market Analysis by Application
  9. 1.3.1 Global Pharmaceutical and Biopharmaceutical Safety Testing Service Market Size Growth Rate by Application: 2021 VS 2025 VS 2032
  10. 1.3.2 Pharmaceutical and Biotechnology Companies
  11. 1.3.3 CROs and CDMOs
  12. 1.3.4 Academic and Research Institutions
  13. 1.4 Global Market Growth Prospects
  14. 1.5 Global Pharmaceutical and Biopharmaceutical Safety Testing Service Growth Trends by Region
  15. 1.5.1 Global Pharmaceutical and Biopharmaceutical Safety Testing Service Market Size by Region: 2021 VS 2025 VS 2032
  16. 1.5.2 Pharmaceutical and Biopharmaceutical Safety Testing Service Market Size by Region (2021-2026)
  17. 1.5.3 Pharmaceutical and Biopharmaceutical Safety Testing Service Market Size by Region (2027-2032)
  18. 1.6 Assumptions and Limitations
  19. 1.7 Study Goals and Objectives
  20. 1.8 Years Considered
2 Global Pharmaceutical and Biopharmaceutical Safety Testing Service Market Dynamics
  1. 2.1 Pharmaceutical and Biopharmaceutical Safety Testing Service Industry Trends
  2. 2.2 Pharmaceutical and Biopharmaceutical Safety Testing Service Industry Drivers
  3. 2.3 Pharmaceutical and Biopharmaceutical Safety Testing Service Industry Opportunities and Challenges
  4. 2.4 Pharmaceutical and Biopharmaceutical Safety Testing Service Industry Restraints
3 Competitive Landscape by Company
  1. 3.1 Global Pharmaceutical and Biopharmaceutical Safety Testing Service Revenue by Company (2021-2026)
  2. 3.2 Global Pharmaceutical and Biopharmaceutical Safety Testing Service Players Revenue Ranking, 2024 VS 2025 VS 2026
  3. 3.3 Global Pharmaceutical and Biopharmaceutical Safety Testing Service Key Company Head office and Area Served
  4. 3.4 Global Pharmaceutical and Biopharmaceutical Safety Testing Service Company, Product Type & Application
  5. 3.5 Global Pharmaceutical and Biopharmaceutical Safety Testing Service Company Establishment Date
  6. 3.6 Market Competitive Analysis
  7. 3.6.1 Global Pharmaceutical and Biopharmaceutical Safety Testing Service Market CR5 and HHI
  8. 3.6.2 Global Top 5 and 10 Pharmaceutical and Biopharmaceutical Safety Testing Service Players Market Share by Revenue in 2025
  9. 3.6.3 2025 Pharmaceutical and Biopharmaceutical Safety Testing Service Tier 1, Tier 2, and Tier 3
4 Pharmaceutical and Biopharmaceutical Safety Testing Service Market by Type
  1. 4.1 Global Pharmaceutical and Biopharmaceutical Safety Testing Service Market Size by Type (2021 VS 2025 VS 2032)
  2. 4.2 Global Pharmaceutical and Biopharmaceutical Safety Testing Service Market Size by Type (2021-2032)
  3. 4.3 Global Pharmaceutical and Biopharmaceutical Safety Testing Service Market Size Share by Type (2021-2032)
5 Pharmaceutical and Biopharmaceutical Safety Testing Service Market by Application
  1. 5.1 Global Pharmaceutical and Biopharmaceutical Safety Testing Service Market Size by Application (2021 VS 2025 VS 2032)
  2. 5.2 Global Pharmaceutical and Biopharmaceutical Safety Testing Service Market Size by Application (2021-2032)
  3. 5.3 Global Pharmaceutical and Biopharmaceutical Safety Testing Service Market Size Share by Application (2021-2032)
6 Company Profiles
  1. 6.1 Eurofins Scientific
  2. 6.1.1 Eurofins Scientific Company Information
  3. 6.1.2 Eurofins Scientific Business Overview
  4. 6.1.3 Eurofins Scientific Pharmaceutical and Biopharmaceutical Safety Testing Service Revenue and Gross Margin (US$ Million) & (2021-2026)
  5. 6.1.4 Eurofins Scientific Pharmaceutical and Biopharmaceutical Safety Testing Service Product Portfolio
  6. 6.1.5 Eurofins Scientific Recent Developments
  7. 6.2 SGS
  8. 6.2.1 SGS Company Information
  9. 6.2.2 SGS Business Overview
  10. 6.2.3 SGS Pharmaceutical and Biopharmaceutical Safety Testing Service Revenue and Gross Margin (US$ Million) & (2021-2026)
  11. 6.2.4 SGS Pharmaceutical and Biopharmaceutical Safety Testing Service Product Portfolio
  12. 6.2.5 SGS Recent Developments
  13. 6.3 Q2 Solutions
  14. 6.3.1 Q2 Solutions Company Information
  15. 6.3.2 Q2 Solutions Business Overview
  16. 6.3.3 Q2 Solutions Pharmaceutical and Biopharmaceutical Safety Testing Service Revenue and Gross Margin (US$ Million) & (2021-2026)
  17. 6.3.4 Q2 Solutions Pharmaceutical and Biopharmaceutical Safety Testing Service Product Portfolio
  18. 6.3.5 Q2 Solutions Recent Developments
  19. 6.4 Samsung Biologics
  20. 6.4.1 Samsung Biologics Company Information
  21. 6.4.2 Samsung Biologics Business Overview
  22. 6.4.3 Samsung Biologics Pharmaceutical and Biopharmaceutical Safety Testing Service Revenue and Gross Margin (US$ Million) & (2021-2026)
  23. 6.4.4 Samsung Biologics Pharmaceutical and Biopharmaceutical Safety Testing Service Product Portfolio
  24. 6.4.5 Samsung Biologics Recent Developments
  25. 6.5 Texcell
  26. 6.5.1 Texcell Company Information
  27. 6.5.2 Texcell Business Overview
  28. 6.5.3 Texcell Pharmaceutical and Biopharmaceutical Safety Testing Service Revenue and Gross Margin (US$ Million) & (2021-2026)
  29. 6.5.4 Texcell Pharmaceutical and Biopharmaceutical Safety Testing Service Product Portfolio
  30. 6.5.5 Texcell Recent Developments
  31. 6.6 WuXi Biologics
  32. 6.6.1 WuXi Biologics Company Information
  33. 6.6.2 WuXi Biologics Business Overview
  34. 6.6.3 WuXi Biologics Pharmaceutical and Biopharmaceutical Safety Testing Service Revenue and Gross Margin (US$ Million) & (2021-2026)
  35. 6.6.4 WuXi Biologics Pharmaceutical and Biopharmaceutical Safety Testing Service Product Portfolio
  36. 6.6.5 WuXi Biologics Recent Developments
  37. 6.7 Wuhan Canvest Biotechnology
  38. 6.7.1 Wuhan Canvest Biotechnology Company Information
  39. 6.7.2 Wuhan Canvest Biotechnology Business Overview
  40. 6.7.3 Wuhan Canvest Biotechnology Pharmaceutical and Biopharmaceutical Safety Testing Service Revenue and Gross Margin (US$ Million) & (2021-2026)
  41. 6.7.4 Wuhan Canvest Biotechnology Pharmaceutical and Biopharmaceutical Safety Testing Service Product Portfolio
  42. 6.7.5 Wuhan Canvest Biotechnology Recent Developments
  43. 6.8 Centre Testing International (CTI)
  44. 6.8.1 Centre Testing International (CTI) Company Information
  45. 6.8.2 Centre Testing International (CTI) Business Overview
  46. 6.8.3 Centre Testing International (CTI) Pharmaceutical and Biopharmaceutical Safety Testing Service Revenue and Gross Margin (US$ Million) & (2021-2026)
  47. 6.8.4 Centre Testing International (CTI) Pharmaceutical and Biopharmaceutical Safety Testing Service Product Portfolio
  48. 6.8.5 Centre Testing International (CTI) Recent Developments
  49. 6.9 Suzhou Liangchen Biotechnology
  50. 6.9.1 Suzhou Liangchen Biotechnology Company Information
  51. 6.9.2 Suzhou Liangchen Biotechnology Business Overview
  52. 6.9.3 Suzhou Liangchen Biotechnology Pharmaceutical and Biopharmaceutical Safety Testing Service Revenue and Gross Margin (US$ Million) & (2021-2026)
  53. 6.9.4 Suzhou Liangchen Biotechnology Pharmaceutical and Biopharmaceutical Safety Testing Service Product Portfolio
  54. 6.9.5 Suzhou Liangchen Biotechnology Recent Developments
  55. 6.10 JADE Biomedical
  56. 6.10.1 JADE Biomedical Company Information
  57. 6.10.2 JADE Biomedical Business Overview
  58. 6.10.3 JADE Biomedical Pharmaceutical and Biopharmaceutical Safety Testing Service Revenue and Gross Margin (US$ Million) & (2021-2026)
  59. 6.10.4 JADE Biomedical Pharmaceutical and Biopharmaceutical Safety Testing Service Product Portfolio
  60. 6.10.5 JADE Biomedical Recent Developments
  61. 6.11 Standard Testing Group
  62. 6.11.1 Standard Testing Group Company Information
  63. 6.11.2 Standard Testing Group Business Overview
  64. 6.11.3 Standard Testing Group Pharmaceutical and Biopharmaceutical Safety Testing Service Revenue and Gross Margin (US$ Million) & (2021-2026)
  65. 6.11.4 Standard Testing Group Pharmaceutical and Biopharmaceutical Safety Testing Service Product Portfolio
  66. 6.11.5 Standard Testing Group Recent Developments
  67. 6.12 Sino Tech World Biologicals
  68. 6.12.1 Sino Tech World Biologicals Company Information
  69. 6.12.2 Sino Tech World Biologicals Business Overview
  70. 6.12.3 Sino Tech World Biologicals Pharmaceutical and Biopharmaceutical Safety Testing Service Revenue and Gross Margin (US$ Million) & (2021-2026)
  71. 6.12.4 Sino Tech World Biologicals Pharmaceutical and Biopharmaceutical Safety Testing Service Product Portfolio
  72. 6.12.5 Sino Tech World Biologicals Recent Developments
  73. 6.13 CAS Testing Technical Services
  74. 6.13.1 CAS Testing Technical Services Company Information
  75. 6.13.2 CAS Testing Technical Services Business Overview
  76. 6.13.3 CAS Testing Technical Services Pharmaceutical and Biopharmaceutical Safety Testing Service Revenue and Gross Margin (US$ Million) & (2021-2026)
  77. 6.13.4 CAS Testing Technical Services Pharmaceutical and Biopharmaceutical Safety Testing Service Product Portfolio
  78. 6.13.5 CAS Testing Technical Services Recent Developments
  79. 6.14 NTEK
  80. 6.14.1 NTEK Company Information
  81. 6.14.2 NTEK Business Overview
  82. 6.14.3 NTEK Pharmaceutical and Biopharmaceutical Safety Testing Service Revenue and Gross Margin (US$ Million) & (2021-2026)
  83. 6.14.4 NTEK Pharmaceutical and Biopharmaceutical Safety Testing Service Product Portfolio
  84. 6.14.5 NTEK Recent Developments
  85. 6.15 Sino Biological
  86. 6.15.1 Sino Biological Company Information
  87. 6.15.2 Sino Biological Business Overview
  88. 6.15.3 Sino Biological Pharmaceutical and Biopharmaceutical Safety Testing Service Revenue and Gross Margin (US$ Million) & (2021-2026)
  89. 6.15.4 Sino Biological Pharmaceutical and Biopharmaceutical Safety Testing Service Product Portfolio
  90. 6.15.5 Sino Biological Recent Developments
  91. 6.16 Miracle Points
  92. 6.16.1 Miracle Points Company Information
  93. 6.16.2 Miracle Points Business Overview
  94. 6.16.3 Miracle Points Pharmaceutical and Biopharmaceutical Safety Testing Service Revenue and Gross Margin (US$ Million) & (2021-2026)
  95. 6.16.4 Miracle Points Pharmaceutical and Biopharmaceutical Safety Testing Service Product Portfolio
  96. 6.16.5 Miracle Points Recent Developments
  97. 6.17 Suzhou Cefety Bioscience
  98. 6.17.1 Suzhou Cefety Bioscience Company Information
  99. 6.17.2 Suzhou Cefety Bioscience Business Overview
  100. 6.17.3 Suzhou Cefety Bioscience Pharmaceutical and Biopharmaceutical Safety Testing Service Revenue and Gross Margin (US$ Million) & (2021-2026)
  101. 6.17.4 Suzhou Cefety Bioscience Pharmaceutical and Biopharmaceutical Safety Testing Service Product Portfolio
  102. 6.17.5 Suzhou Cefety Bioscience Recent Developments
  103. 6.18 Zhejiang Hengyu Biological
  104. 6.18.1 Zhejiang Hengyu Biological Company Information
  105. 6.18.2 Zhejiang Hengyu Biological Business Overview
  106. 6.18.3 Zhejiang Hengyu Biological Pharmaceutical and Biopharmaceutical Safety Testing Service Revenue and Gross Margin (US$ Million) & (2021-2026)
  107. 6.18.4 Zhejiang Hengyu Biological Pharmaceutical and Biopharmaceutical Safety Testing Service Product Portfolio
  108. 6.18.5 Zhejiang Hengyu Biological Recent Developments
  109. 6.19 Merck
  110. 6.19.1 Merck Company Information
  111. 6.19.2 Merck Business Overview
  112. 6.19.3 Merck Pharmaceutical and Biopharmaceutical Safety Testing Service Revenue and Gross Margin (US$ Million) & (2021-2026)
  113. 6.19.4 Merck Pharmaceutical and Biopharmaceutical Safety Testing Service Product Portfolio
  114. 6.19.5 Merck Recent Developments
  115. 6.20 Charles River Laboratories
  116. 6.20.1 Charles River Laboratories Company Information
  117. 6.20.2 Charles River Laboratories Business Overview
  118. 6.20.3 Charles River Laboratories Pharmaceutical and Biopharmaceutical Safety Testing Service Revenue and Gross Margin (US$ Million) & (2021-2026)
  119. 6.20.4 Charles River Laboratories Pharmaceutical and Biopharmaceutical Safety Testing Service Product Portfolio
  120. 6.20.5 Charles River Laboratories Recent Developments
  121. 6.21 Sartorius
  122. 6.21.1 Sartorius Company Information
  123. 6.21.2 Sartorius Business Overview
  124. 6.21.3 Sartorius Pharmaceutical and Biopharmaceutical Safety Testing Service Revenue and Gross Margin (US$ Million) & (2021-2026)
  125. 6.21.4 Sartorius Pharmaceutical and Biopharmaceutical Safety Testing Service Product Portfolio
  126. 6.21.5 Sartorius Recent Developments
7 North America
  1. 7.1 North America Pharmaceutical and Biopharmaceutical Safety Testing Service Market Size (2021-2032)
  2. 7.2 North America Pharmaceutical and Biopharmaceutical Safety Testing Service Market Size by Type
  3. 7.2.1 North America Pharmaceutical and Biopharmaceutical Safety Testing Service Market Size by Type (2021-2026)
  4. 7.2.2 North America Pharmaceutical and Biopharmaceutical Safety Testing Service Market Size by Type (2027-2032)
  5. 7.2.3 North America Pharmaceutical and Biopharmaceutical Safety Testing Service Market Share by Type (2021-2032)
  6. 7.3 North America Pharmaceutical and Biopharmaceutical Safety Testing Service Market Size by Application
  7. 7.3.1 North America Pharmaceutical and Biopharmaceutical Safety Testing Service Market Size by Application (2021-2026)
  8. 7.3.2 North America Pharmaceutical and Biopharmaceutical Safety Testing Service Market Size by Application (2027-2032)
  9. 7.3.3 North America Pharmaceutical and Biopharmaceutical Safety Testing Service Market Share by Application (2021-2032)
  10. 7.4 North America Pharmaceutical and Biopharmaceutical Safety Testing Service Market Size by Country
  11. 7.4.1 North America Pharmaceutical and Biopharmaceutical Safety Testing Service Market Size by Country (2021 VS 2025 VS 2032)
  12. 7.4.2 North America Pharmaceutical and Biopharmaceutical Safety Testing Service Market Size by Country (2021-2026)
  13. 7.4.3 North America Pharmaceutical and Biopharmaceutical Safety Testing Service Market Size by Country (2027-2032)
  14. 7.4.4 North America Pharmaceutical and Biopharmaceutical Safety Testing Service Market Share by Country (2021-2032)
  15. 7.4.5 United States
  16. 7.4.6 Canada
  17. 7.4.7 Mexico
8 Europe
  1. 8.1 Europe Pharmaceutical and Biopharmaceutical Safety Testing Service Market Size (2021-2032)
  2. 8.2 Europe Pharmaceutical and Biopharmaceutical Safety Testing Service Market Size by Type
  3. 8.2.1 Europe Pharmaceutical and Biopharmaceutical Safety Testing Service Market Size by Type (2021-2026)
  4. 8.2.2 Europe Pharmaceutical and Biopharmaceutical Safety Testing Service Market Size by Type (2027-2032)
  5. 8.2.3 Europe Pharmaceutical and Biopharmaceutical Safety Testing Service Market Share by Type (2021-2032)
  6. 8.3 Europe Pharmaceutical and Biopharmaceutical Safety Testing Service Market Size by Application
  7. 8.3.1 Europe Pharmaceutical and Biopharmaceutical Safety Testing Service Market Size by Application (2021-2026)
  8. 8.3.2 Europe Pharmaceutical and Biopharmaceutical Safety Testing Service Market Size by Application (2027-2032)
  9. 8.3.3 Europe Pharmaceutical and Biopharmaceutical Safety Testing Service Market Share by Application (2021-2032)
  10. 8.4 Europe Pharmaceutical and Biopharmaceutical Safety Testing Service Market Size by Country
  11. 8.4.1 Europe Pharmaceutical and Biopharmaceutical Safety Testing Service Market Size by Country (2021 VS 2025 VS 2032)
  12. 8.4.2 Europe Pharmaceutical and Biopharmaceutical Safety Testing Service Market Size by Country (2021-2026)
  13. 8.4.3 Europe Pharmaceutical and Biopharmaceutical Safety Testing Service Market Size by Country (2027-2032)
  14. 8.4.4 Europe Pharmaceutical and Biopharmaceutical Safety Testing Service Market Share by Country (2021-2032)
  15. 8.4.5 Germany
  16. 8.4.6 France
  17. 8.4.7 U.K.
  18. 8.4.8 Italy
  19. 8.4.9 Russia
  20. 8.4.10 Nordic Countries
9 China
  1. 9.1 China Pharmaceutical and Biopharmaceutical Safety Testing Service Market Size (2021-2032)
  2. 9.2 China Pharmaceutical and Biopharmaceutical Safety Testing Service Market Size by Type
  3. 9.2.1 China Pharmaceutical and Biopharmaceutical Safety Testing Service Market Size by Type (2021-2026)
  4. 9.2.2 China Pharmaceutical and Biopharmaceutical Safety Testing Service Market Size by Type (2027-2032)
  5. 9.2.3 China Pharmaceutical and Biopharmaceutical Safety Testing Service Market Share by Type (2021-2032)
  6. 9.3 China Pharmaceutical and Biopharmaceutical Safety Testing Service Market Size by Application
  7. 9.3.1 China Pharmaceutical and Biopharmaceutical Safety Testing Service Market Size by Application (2021-2026)
  8. 9.3.2 China Pharmaceutical and Biopharmaceutical Safety Testing Service Market Size by Application (2027-2032)
  9. 9.3.3 China Pharmaceutical and Biopharmaceutical Safety Testing Service Market Share by Application (2021-2032)
10 Asia (Excluding China)
  1. 10.1 Asia Pharmaceutical and Biopharmaceutical Safety Testing Service Market Size (2021-2032)
  2. 10.2 Asia Pharmaceutical and Biopharmaceutical Safety Testing Service Market Size by Type
  3. 10.2.1 Asia Pharmaceutical and Biopharmaceutical Safety Testing Service Market Size by Type (2021-2026)
  4. 10.2.2 Asia Pharmaceutical and Biopharmaceutical Safety Testing Service Market Size by Type (2027-2032)
  5. 10.2.3 Asia Pharmaceutical and Biopharmaceutical Safety Testing Service Market Share by Type (2021-2032)
  6. 10.3 Asia Pharmaceutical and Biopharmaceutical Safety Testing Service Market Size by Application
  7. 10.3.1 Asia Pharmaceutical and Biopharmaceutical Safety Testing Service Market Size by Application (2021-2026)
  8. 10.3.2 Asia Pharmaceutical and Biopharmaceutical Safety Testing Service Market Size by Application (2027-2032)
  9. 10.3.3 Asia Pharmaceutical and Biopharmaceutical Safety Testing Service Market Share by Application (2021-2032)
  10. 10.4 Asia Pharmaceutical and Biopharmaceutical Safety Testing Service Market Size by Country
  11. 10.4.1 Asia Pharmaceutical and Biopharmaceutical Safety Testing Service Market Size by Country (2021 VS 2025 VS 2032)
  12. 10.4.2 Asia Pharmaceutical and Biopharmaceutical Safety Testing Service Market Size by Country (2021-2026)
  13. 10.4.3 Asia Pharmaceutical and Biopharmaceutical Safety Testing Service Market Size by Country (2027-2032)
  14. 10.4.4 Asia Pharmaceutical and Biopharmaceutical Safety Testing Service Market Share by Country (2021-2032)
  15. 10.4.5 Japan
  16. 10.4.6 South Korea
  17. 10.4.7 Taiwan
  18. 10.4.8 Southeast Asia
  19. 10.4.9 India
  20. 10.4.10 Australia
11 South America, Middle East & Africa
  1. 11.1 South America, Middle East & Africa Pharmaceutical and Biopharmaceutical Safety Testing Service Market Size (2021-2032)
  2. 11.2 South America, Middle East & Africa Pharmaceutical and Biopharmaceutical Safety Testing Service Market Size by Type
  3. 11.2.1 South America, Middle East & Africa Pharmaceutical and Biopharmaceutical Safety Testing Service Market Size by Type (2021-2026)
  4. 11.2.2 South America, Middle East & Africa Pharmaceutical and Biopharmaceutical Safety Testing Service Market Size by Type (2027-2032)
  5. 11.2.3 South America, Middle East & Africa Pharmaceutical and Biopharmaceutical Safety Testing Service Market Share by Type (2021-2032)
  6. 11.3 South America, Middle East & Africa Pharmaceutical and Biopharmaceutical Safety Testing Service Market Size by Application
  7. 11.3.1 South America, Middle East & Africa Pharmaceutical and Biopharmaceutical Safety Testing Service Market Size by Application (2021-2026)
  8. 11.3.2 South America, Middle East & Africa Pharmaceutical and Biopharmaceutical Safety Testing Service Market Size by Application (2027-2032)
  9. 11.3.3 South America, Middle East & Africa Pharmaceutical and Biopharmaceutical Safety Testing Service Market Share by Application (2021-2032)
  10. 11.4 South America, Middle East & Africa Pharmaceutical and Biopharmaceutical Safety Testing Service Market Size by Country
  11. 11.4.1 South America, Middle East & Africa Pharmaceutical and Biopharmaceutical Safety Testing Service Market Size by Country (2021 VS 2025 VS 2032)
  12. 11.4.2 South America, Middle East & Africa Pharmaceutical and Biopharmaceutical Safety Testing Service Market Size by Country (2021-2026)
  13. 11.4.3 South America, Middle East & Africa Pharmaceutical and Biopharmaceutical Safety Testing Service Market Size by Country (2027-2032)
  14. 11.4.4 South America, Middle East & Africa Pharmaceutical and Biopharmaceutical Safety Testing Service Market Share by Country (2021-2032)
  15. 11.4.5 Brazil
  16. 11.4.6 South Africa
  17. 11.4.7 Saudi Arabia
  18. 11.4.8 Turkey
  19. 11.4.9 Argentina
  20. 11.4.9 UAE
  21. 11.4.9 Egypt
  22. 11.4.9 Chile
12 Concluding Insights
    13 Appendix
    1. 13.1 Reasons for Doing This Study
    2. 13.2 Research Methodology
    3. 13.3 Research Process
    4. 13.4 Authors List of This Report
    5. 13.5 Data Source
    6. 13.5.1 Secondary Sources
    7. 13.5.2 Primary Sources
    8. 13.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst